Category Archives: Health

What is new in the field of Health. Trending topics, and cutting edge research in the are of Health. Press Releases that give us updates on Health.

Autism Learning Partners launches Center-Based ABA Therapy for Individuals in Westerville, OH


“We’re excited to expand our Ohio center-based services offered in Cleveland to the Columbus area with individualized ABA services focused on building skills in socially significant areas through engaging interactions with peers,” said Rachael Schneider, M.A., BCBA-LBA, Executive Director at ALP.

ALP strives to give hope, support, and paths of progress for children and their families living with autism and related disorders. With their robust network of community partnerships and ever-growing list of accepted insurances, families can receive quality support. ALP believes a tailored, comprehensive care plan with a dedicated clinical team allows children and their family units to experience the most progress possible.

“We are excited to expand our Ohio center-based services offered in Cleveland to the Columbus area! We offer individualized ABA services in our uniquely designed center. We focus on building skills in socially significant areas through engaging interactions with peers that includes gross motor areas, sensory areas, and much more!,” said Rachael Schneider, M.A., BCBA-LBA, Executive Director at ALP. “Our centers offer increased resources, school readiness skills, generalization, a consistent clinical team, social opportunities and caregiver collaboration.”

ALP is a national leader in the special needs field since 1988. Headquartered in Monrovia, CA, they employ over 300 Board Certified Behavior Analysts (“BCBAs”) and have a total workforce of 3,400 nationwide, including Behavior Technicians providing home and center-based Applied Behavior Analysis (ABA) therapies. Services include: ABA care, as well as speech, occupational, physical therapies, and diagnostic services in select regions. ALP now offers treatment in 17 states including California, Colorado, Connecticut, Florida, Georgia, Maryland, Massachusetts, New Jersey, New Mexico, New York, North Carolina, Ohio, Oregon, Rhode Island, Texas, Utah, and Virginia.

To learn more about Autism Learning Partners and its services, please visit http://www.AutismLearningPartners.com.

Share article on social media or email:

New Behavioral Health Business Outlook Report Shows Providers Ready to Expand Care Services and Revenue Opportunities Despite Staff-Driven Financial Strain


Behavioral Health Business, an Aging Media publication, has released the results of its 2023 Behavioral Health Outlook Survey and Report, identifying the top challenges and opportunities for providers of behavioral, mental health and substance use services. Participants expressed an overall optimism around referral growth opportunities, even while nearly 80% indicated the coming financial strain of health care’s staffing crisis.

To help solve that crisis, providers indicate a continued rise in their utilization of technology tools, starting with telehealth. They view a fairly even spread of growth opportunities in the industry for 2023, split between treating underserved populations, pursuing value-based relationships and expanding service offerings. Also evenly spread across online and internet searches, community referrals and physician offices.

Behavioral Health Business conducted the survey to learn how providers are navigating the difficult road to recovery and growth in a post-pandemic future. The results show the views of 150 professionals who identify as working for organizations that provide treatment for behavioral health, mental health and substance use disorders, painting a vivid picture of the industry-wide sentiment for the year to come.

In summary, respondents indicated:


  • Growth opportunities abound in behavioral health — Providers expect to see the greatest growth in partnerships during 2023, citing online and internet searches (27% of respondents), community referrals (27%) and physician offices (22%) as the greatest anticipated referral growth sources.
  • An overwhelming majority indicate staffing-related financial strain in 2023 — Seventy-seven percent of respondents indicated that staffing changes will also be the greatest area of financial strain in the behavioral health industry for 2023. More than half of respondents cited staffing as the industry’s biggest current challenge.
  • Providers are focused on value and accessibility while investors key in on mental health — Treating underserved populations (27% of respondents), pursuing value-based relationships (26%) and expanding service offerings (23%) are the top three opportunities in behavioral health for the year ahead, with mental health representing the most attractive investment target in behavioral health.
  • Telehealth use for behavioral health care will rise in 2023 — When it comes to digital health care tools, more than half of survey participants are most excited about telehealth in 2023. Thirty-eight percent of respondents believe telehealth use in behavioral health will increase relative to 2022.

“Day by day, care providers are seeing the opportunity to get behavioral and mental health services to more Americans through a combination of technology deployment and community and hospital partnerships,” said Behavioral Health Business Editor Laura Lovett. “The rising interest in investing in mental health care reveals just how vital this industry is today.”

The survey was conducted online between November 14, 2022, and December 26, 2022. Access the full survey results here.

About Aging Media Network and Behavioral Health Business

Aging Media Network, an innovative publishing company based in Chicago, Illinois, is the publisher of Behavioral Health Business, Senior Housing News, Home Health Care News, Skilled Nursing News and Hospice News. Behavioral Health Business is the leading source for news and information covering the industries of behavioral and mental health care.

Share article on social media or email:

Novita Pharmaceuticals Appoints Alan Wills as Its Chief Executive Officer


Novita Pharmaceuticals, Inc. (“Novita” or the “Company”), a privately held clinical-stage pharmaceutical company dedicated to developing novel cancer drugs based on its proprietary fascin inhibitor technology, today announced that the Company’s Board of Directors has appointed Alan Wills as its Chief Executive Officer.

Mr. Wills joined Novita as Chief Executive Officer on February 6, 2023, bringing extensive experience in the global biopharmaceutical industry, notably in business development, corporate strategy, M&A and licensing, and alliance management. Prior to joining Novita. Mr. Wills was Executive Vice President, Strategy & Business Development, at CSL Group. He previously served in a range of progressively senior level roles in Corporate Strategy, Business Development, Global Marketing and Portfolio Management at Pfizer, Bristol-Myers Squibb, and Auxilium Pharmaceuticals. In his earlier career, he worked at the Boston Consulting Group, Lucile Packard Children’s Hospital at Stanford, and United Healthcare. He holds a Master of Business Administration from Harvard Business School.

“Alan is a seasoned pharmaceutical senior executive and a strong strategic thinker and executer,” said Dr. Xin-Yun Huang, Chairman of the Board and a co-founder of Novita. “He brings a depth of business experience and acumen that will be a perfect complement to Novita’s founding team.”

“We are delighted to have recruited a talent like Alan,” said Dr. Jillian Zhang, President and Chief Scientific Officer, and a co-founder of Novita. “Our Company’s first-in-class fascin inhibitor NP-G2-044 is in the midst of a phase 2 clinical study. It is great timing for Alan to join us at this stage as we continue to advance the development of NP-G2-044 as a breakthrough cancer therapy.”

“It’s an exciting time to join Novita, with the Company’s lead compound moving through its phase 2 program and generating solid early data,” said Mr. Wills. “I look forward to helping Novita advance the development of new and innovative cancer therapies that will address critical unmet medical needs.”

About Novita Pharmaceuticals, Inc.

Novita Pharmaceuticals, Inc. (“Novita” or the “Company”) is a privately held clinical-stage biopharmaceutical company dedicated to developing ground-breaking drugs based on its proprietary fascin inhibitor technology to prevent and treat cancer metastasis and at the same time to boost anti-cancer immune responses. Cancer metastasis is the primary cause of over 90% of deaths of cancer patients and yet there is no drug specifically and directly targeting metastasis on the market today. In addition, while Immuno-Oncology (IO) with anti-PD-1 immune checkpoint inhibitors has made a significant impact on the treatment of many types of cancer, most cancer patients do not respond to current IO treatments. Novita aims to address both these important medical needs by developing inhibitors of fascin, a key protein critically involved in tumor cell motility and highly expressed in tumor cells and in antigen-presenting cells in the tumor tissues. The Company’s lead asset, a small-molecule fascin inhibitor NP-G2-044 has been shown in preclinical studies to block tumor cell migration, invasion, and metastasis. In animal models, NP-G2-044 in combination with immune checkpoint inhibitors demonstrated synergistic efficacy that tripled overall survival rates in comparison to IO alone. The multicenter Phase 2 clinical trial of NP-G2-044 titled “NP-G2-044 as Monotherapy and Combination Therapy in Patients with Advanced or Metastatic Solid Tumor Malignancies” is currently ongoing and open for patient enrollment.

For more clinical trial information, please go to:

https://clinicaltrials.gov/ct2/show/NCT05023486

Cautionary Note Regarding Forward-Looking Statements

This press release contains certain forward-looking statements. Such statements are subject to risks and uncertainties that could cause actual results to differ materially from those projected in the forward-looking statements. These statements are based on a number of assumptions and estimates that are inherently subject to significant uncertainties and contingencies, many of which are beyond the Company’s control, and reflect future business decisions, which are subject to change. Among those factors that could cause actual results to differ materially from those described in the forward-looking statements are the risks associated with the Company’s being a development stage company with uncertain revenue streams; uncertain results or outcomes during clinical trials; certain rights owned by others over the Company’s intellectual property; failure to raise necessary capital in the future; the loss of key personnel; competition from other larger, better-capitalized peers; the Company’s reliance on incorrect assumptions regarding the market for its products, the costs of developing, manufacturing and marketing the Company’s products, and the timing and receipt of regulatory approval for the Company’s products; adverse economic conditions; and other risks. In light of the significant uncertainties inherent in the forward-looking statements, the inclusion of any such statement should not be regarded as a representation by Novita or any other person that the Company’s objectives or plans will be achieved.

Contact Info:

Christy Shue

cshue@novita-pharm.com

Share article on social media or email:

Gaize announces the launch of their real-time impairment screening device for cannabis and other drugs


Gaize being used at construction site

“Gaize was created to solve the problem of cannabis and drug impaired drivers and safety-sensitive workers. It’s a rapid screening tool that’s portable, non-invasive, and based on eye-movement tests with a long history of successful use.” – Ken Fichtler, Gaize Founder and CEO

Today, Gaize announced the launch of their real-time impairment screening device. The product is a first-of-its-kind fully automated, non-invasive and portable eye movement test. It combines well-established Drug Recognition Expert (DRE) eye examinations with the latest in artificial intelligence. Drug Recognition Expert eye tests are widely considered the gold standard for impairment detection, with 40+ years of successful use, many scientific studies on their effectiveness, and court acceptance in all 50 states. Gaize runs these same tests, exactly according to the DRE training manual, using a VR headset with embedded eye tracking sensors. The resulting data is then analyzed by machine learning models to discover involuntary eye movement changes which are correlated with impairment. This product launch comes following a recently completed clinical trial using the Gaize product, which was the largest in the world to ever investigate cannabis impairment.

Ken Fichtler, Gaize Founder and CEO said: “I created Gaize to solve the problem of cannabis impaired drivers and workers. THC behaves markedly differently in the body than does alcohol, and it can linger in the body for over a month since the last use. No amount of THC in the body has never been shown to produce a predictable level of impairment, so simply measuring THC is not indicative of impairment. Particularly in places where cannabis is legal, what we really care about is whether or not someone is impaired, not if they’ve used cannabis previously.”The results of the test are easy to interpret and each test is also backed by video evidence of the eye movement. From this, Gaize customers can easily and confidently make defensible decisions. Results are delivered in just 6 minutes from the time the test is started, enabling much more frequent impairment screening.

Fichtler said, “We envision a world where drivers and workers are verifiably sober before engaging in any safety sensitive task. With Gaize, companies can test employees each day before the start of shift, after a lunch break, or before operating equipment.”Fichtler ended by saying “We’ve had our heads down following the science and building this product for over two years. To have it come to market today feels great. It’s going to be truly revolutionary for maintaining safe roads and workplaces with fewer preventable impairment related deaths and injuries.”

The product is available to commercial customers starting today. To learn more, visit http://www.gaize.ai.

Members of the Press are encouraged to contact support@gaize.ai.

Share article on social media or email:

The GHT Companies to Showcase its Manufacturing Capabilities and Retail Lines at Natural Products Expo West 2023


The GHT Companies Exhibiting at Expo West 2023

“We value this show because, as a recognized authority in contract manufacturing, productformulation, and sourcing for raw materials, we make some of our most valuableconnections and develop mutually beneficial business relationships during Expo West,”GHT Companies President & CEO Jim Rex.

The GHT Companies, a decades-long leader in the natural supplement formulation/manufacturing/market distribution space, has announced its attendance at Natural Products Expo West 2023 to showcase its start-to-finish product services – from access to exclusive raw ingredient discoveries with founding scientists from around the globe, product ideation, product formulation, and manufacturing through their acclaimed production company, Health Specialties Manufacturing, all the way to market distribution for private label lines or in one of their own established branded product lines: Vegan Life Nutrition, Global Health Trax, and Vibrant Nutraceuticals.

From March 9-11, The GHT Companies will be at Booth #3472 in Hall D of the Anaheim Convention Center to discuss partnership opportunities with:

● Retailers who are looking for products to improve their margins can explore vitamins and supplements from GHT’s three branded lines: Vegan Life Nutrition, Vibrant Nutraceuticals, and Global Health Trax.

● Private label lines in the market for highly-vetted and innovative raw ingredients and top quality formulation and manufacturing.

● Founding scientists in need of the highest-quality formulation and/or manufacturing partner to bring their product to life and to market.

“We value this show because, as a recognized authority in contract manufacturing, product formulation, and sourcing for raw materials, we make some of our most valuable connections and develop mutually beneficial business relationships during Expo West,” said GHT Companies President & CEO Jim Rex. “We’re looking forward to taking on new partnerships with companies in all stages of the product journey – whether they’re looking for quality ingredient sourcing, product formulation, manufacturing, complex packaging, or top-quality products to improve their retail margins, we’re ready to help them through it all,” Rex added.

GHT offers impressive manufacturing capabilities such as complex powder blending, cold-fill liquids, and supplement encapsulation, and heralds its “Three Zeros”:

● Zero “minimum order” requirements: GHT handles both large and small order quantities.

● Zero product recalls: Even after decades of business, GHT has never had a formal recall on any of the products they have manufactured.

● Zero failed audits: GHT has proudly never failed a federal, state, or third-party audit, and they maintain over nine industry certifications.

In addition to GHT’s contract manufacturing services, the company will also be showcasing its three branded supplement lines (Vegan Life Nutrition, Global Health Trax, and Vibrant Nutraceuticals), each of which features products containing exclusive raw ingredients from partnerships with founding scientists from around the world.

At the show, retailers and customers alike will be able to sample some of these brands’ newest and most innovative products, including probiotics, spray vitamins, and even chewing gums that provide seasonal support.

You can schedule a meeting with GHT before or during Natural Products Expo West 2023 on their website.

About The GHT Companies

The GHT Companies is a collection of four specific operational business units that work together to translate scientific discovery into business enterprise. From the research and development of cutting-edge ingredients and product formulation and testing to manufacturing and distribution, GHT is a complete resource for taking high-quality products to commercial markets worldwide.

Our partnership starts from the beginning of the product cycle: we vet, champion, and continuously support top scientists who have discovered new ingredients for nutritional supplements and vitamins. With our extensive network of resources, we provide a clear pathway to bring these discoveries to market and into the hands of consumers. We have access to the manufacturing, packaging, marketing and distribution systems needed to turn formulations into sought-after products. GHT’s consumer-facing brands act as vehicles for introducing new discoveries to consumers and making them available for purchase.

Next, we partner with private label companies that seek superior, reliable products that provide both quality and consistency. We continuously research, source, and manufacture new products so partnering companies have access to the most exciting products available. As we continue to develop new products, our private label partners can consistently add innovative and cutting-edge products to their lines.

With years of experience and devotion to finding new formulations, we are the industry leader in providing the most reliable raw ingredients on the market. Our manufacturing partners feel at ease knowing that we maintain the highest standards, supplying safe and compliant ingredients that reflect the integrity of their brands.

Media Contact:

Marketing Department, request Shanna Denfeld, Vice-President

(760) 542-3000

marketing@theghtcompanies.com

Share article on social media or email:

The Fenway Institute and NORC


Rectangular blue Fenway Health logo, blue background with white text

This is the first analysis to our knowledge to document the elevated prevalence of kidney disease among older adults in the U.S. who are lesbian, gay, bisexual, or a sexual orientation other than heterosexual.

According to a new study by researchers from NORC at the University of Chicago, The Fenway Institute, and the Centers for Medicare & Medicaid Services (CMS), sexual minority (LGBT+) men and women over age 50 are more likely to have kidney disease compared to their heterosexual peers.

The study, published online in the Journal of the American Society of Nephrology, found that 6.23 percent of older sexual minority men had kidney disease compared to 4.81 percent of heterosexual men, while 5.97 percent of older sexual minority women reported a kidney disease diagnosis compared with 4.88 percent of heterosexual women. In addition, the study found a higher incidence of risk factors for kidney disease—smoking, activity limitations, adverse health outcomes, and limited access to health care, housing, and employment—among older LGBT+ people.

“This is the first analysis to our knowledge to document the elevated prevalence of kidney disease among older adults in the U.S. who are lesbian, gay, bisexual, or a sexual orientation other than heterosexual,” said Sean Cahill, coauthor and director of Health Policy Research at the Fenway Institute. “Even after adjusting for demographics and risk factors, older gay and bisexual men were nearly twice as likely as older heterosexual men to report a kidney disease diagnosis.”

Despite well-documented disparities in chronic kidney disease risk factors such as diabetes and hypertension in LGBT+ adults, there have been limited studies examining kidney disease prevalence in this population.

“These results support increasing access to screening for kidney disease risk factors in this population, providing culturally responsive care, and addressing societal drivers of vulnerability in older LGBT+ adults,” added Mollie Hertel, coauthor and senior research scientist at NORC.

Study results were developed using data from the Behavioral Risk Factor Surveillance System (BRFSS). The BRFSS introduced sexual orientation and gender identity questions in 2014. NORC analyzed BRFSS data from 2014 to 2019 to determine self-reported kidney disease prevalence in LGBT+ older adults (50+) compared to their heterosexual peers.

“This research suggests that national surveys such as the BRFSS should work toward developing standardized, consistent, and tested kidney disease nomenclature to ensure it captures an accurate estimate of kidney disease prevalence for future surveillance efforts,” said Meghana Chandra, coauthor and research scientist at NORC.

The study is scheduled to be published in print versions of the journal later this year.

Share article on social media or email:

New Skilled Nursing News Outlook Report Shows 56% of Providers Anticipate Increased Long-Term Care Occupancy in 2023


Skilled Nursing News, an Aging Media publication, has released the results of its 2023 Skilled Nursing Outlook Survey, identifying the top challenges and opportunities in the year ahead for providers of skilled care and post-acute rehab. Participants expressed knowledge of the tough road ahead in staffing, countered by optimism over increased occupancy rates.

Asked to describe the occupancy outlook for 2023, more than half of respondents predicted an occupancy rate increase in long-term care (56%) as well as in skilled nursing and post-acute rehab (53%). But staffing remains a challenge: respondents identified recruitment/retention as the clear-cut greatest challenge the industry faces this year (53%). To help them provide great care and overcome the staffing shortage, 38% of respondents will invest in technology while 34% will deepen their relationships with ACOs.

Skilled Nursing News conducted the survey in partnership with EHR provider Net Health to learn how providers are tackling today’s most pressing problems. The results show the views of 272 professionals who identify as working for organizations that provide skilled nursing, painting a picture of an industry working diligently to get out from behind the eight ball.

Survey results provide perspective and context around the industry’s outlook in staffing, occupancy, technology and M&A.

In summary, respondents indicated:


  • Occupancy optimism for 2023 — 53% of respondents believe that occupancy rates for skilled nursing and post-acute rehab will rise in 2023, with 56% of respondents predicting a rise in occupancy rates for long-term care residents.
  • A deep focus on organic growth — 54% of qualified respondents indicated their organization plans to hold skilled nursing assets in 2023, and 53% are seeking financing from banks and finance companies over other sources.
  • Tough days for staffing continue — More than half of survey respondents believe recruitment and retention will be skilled nursing’s greatest challenge in 2023, with 43% believing hiring will not improve until 2024 or later.

“No health care sector was hit harder by the pandemic than skilled nursing and post-acute care, and the leaders in the industry responded with compassion, focus — and a new attention to technology tools,” said Skilled Nursing News Managing Editor Tim Mullaney. “Though pandemic recovery is ongoing, the results from our survey with Net Health reveal a continued surge of optimism and activity.”

“We are pleased to support SNN’s work in gathering data about the state of the skilled nursing industry,” says Net Health CEO Josh Pickus. “We are aware of the many challenges facing our skilled nursing clients and hope the survey provides insights to help providers better navigate the months ahead.”

The survey was conducted online between October 17, 2022, and December 5, 2022. Access the full survey results here.

About Aging Media Network and Skilled Nursing News

Aging Media Network, an innovative publishing company based in Chicago, Illinois, is the publisher of Skilled Nursing News, Senior Housing News, Home Health Care News, Hospice News and Behavioral Health Business. Skilled Nursing News is the leading source for news and information covering the skilled nursing and post-acute care industry.

About Net Health

Net Health’s mission is to harness data for human health. Net Health solutions are trusted in over 23,000 facilities across the continuum of care. Our EHR software enables caregivers and their organizations to engage effectively with patients, streamline documentation, staff efficiently, secure maximum appropriate reimbursement and maintain regulatory compliance. Our unique approach to analytics seamlessly presents insights in clinical and operational workflows to improve care and business performance. Net Health is a portfolio company of The Carlyle Group, Level Equity and Silversmith Capital Partners. http://www.nethealth.com.

Share article on social media or email:

International Medical Relief Dispatches Disaster Relief Volunteers to Turkey


“We have experience working in these types of crisis situations, and they immediately accepted our offer for assistance.”

International Medical Relief (IMR), a non-governmental organization based in Denver, Colorado, has dispatched a team of medical volunteers to Turkey to provide medical care, equipment, medicines and education for survivors of the Turkey-Syria Earthquake.

“We reached out to our long-term partners in Turkey who were working on a clinical outreach program to underserved communities and had shifted their efforts to focus on the earthquake victims,” said Shauna King, president of IMR. “We have experience working in these types of crisis situations, and they immediately accepted our offer for assistance.”

IMR has a Colorado-based Disaster Area Response Team (DART) of doctors, nurses, and EMTs in the field at ground zero working on the logistics to accept the first volunteer team, which leaves for Turkey today. The DART also delivered medicine and medical supplies for basic first aid, trauma care, and wound care, which are in short supply.

IMR has been working on the front lines of the Ukrainian refugee crisis for nearly a year organizing upwards of 700 medical professionals and nonmedical staff to serve more than 365,000 refugees in shelters in Poland. The recovery and regenerative healthcare efforts are still operating in those shelters, but IMR was able to expand relief efforts to allow for a Turkey-Syria response as well.

Founded in 2002, IMR has responded to catastrophic disasters around the world. The organization’s preparedness operations have served 84 countries, many of which are vulnerable to disasters.

International Medical Relief is actively recruiting volunteers to serve weeklong assignments and is collecting donations. Information is available on the organization’s website, internationalmedicalrelief.org.

About International Medical Relief: International Medical Relief (IMR), a non-governmental organization based in Denver, Colorado, contributes to the world’s communities by improving the overall health and wellness of the people via medical and dental diagnosis and treatment, partnerships with local medical designees, community training, and fostering the principles of prevention. IMR recruits highly skilled, credentialed volunteers for medical, dental, and disaster relief trips throughout the year to deliver a much-needed suite of impactful services. Learn more at internationalmedicalrelief.org.

Share article on social media or email:

THE JUSTIN SPORTSMEDICINE TEAM ®


Justin Sportsmedicine Team®

All rodeo contestants know that it’s not a matter of if they get hurt, it’s a matter of when and how badly. The Justin Sportsmedicine Team® is there to prevent injuries and treat them when they occur. Over the course of 21 PRCA performances at the Fort Worth Stock Show & Rodeo, the Justin Sportsmedicine Team® treated 723 injuries.

The Justin Sportsmedicine Team® saw 301 contestants and treated 519 body parts. 238 athletes utilized the Justin Sportsmedicine Team® program by self-taping, which alleviates pain and takes some of the workload off of the athlete’s muscles. During the Fort Worth Stock Show & Rodeo, the Justin Sportsmedicine Team® used 9,600 yards of white tape and 1,680 yards of elastic tape.

The Justin Sportsmedicine Team® program couldn’t run without the help of volunteers that are committed to giving back to the rodeo and the athletes. These volunteers are the heart and soul of the program and the Justin Sportsmedicine Team® would not be able to cover 125 different rodeos each year. At the Fort Worth Stock Show & Rodeo, were 20 athletic trainers, two orthopedic surgeons, one primary care sports medicine physician, and one vascular surgeon. Additionally, 16 volunteer athletic trainers supported the four program managers who split time in Fort Worth.

“It is our calling to serve rodeo athletes who are some of the toughest in all of sports,” said Mike Rich, Executive Director of the Justin Sportsmedicine Team®. “It is a great privilege to work in a state-of-the-art sports medicine facility like they built for us at the Fort Worth Stock Show & Rodeo.”

The Justin Sportsmedicine Team® proudly provides service to over 125 PRCA rodeos annually while treating around 8,000 cases. The Justin Sportsmedicine Team® has three trailers that act as mobile sports medicine centers, each covering over 87,000 miles each year providing comprehensive medical services to the men and women of the Pro Rodeo Cowboys Association and Women’s Professional Rodeo Association. To learn more about the Justin Sportsmedicine Team®, visit http://www.justinsportsmedicineteam.com.

About Justin Sportsmedicine Team®

The Justin Sportsmedicine Team® began in 1980 when Dr. J Pat Evans and Don Andrews developed the concept of a mobile sports medicine system that would provide medical support services to professional rodeo athletes at arenas where they competed across the country. This innovative new sports medicine system linked a network of selected emergency physicians, orthopedists, trauma specialists, athletic trainers, physical therapists, and physician assistants, as well as hospitals and clinics around the nation to provide comprehensive medical coverage to the professional rodeo contestant. From its modest beginnings at some 10 Professional Rodeo Cowboy Association (PRCA) sanctioned rodeos and just 775 contestants treated the first year, the Justin Sportsmedicine Team® currently provides service to over 125 PRCA rodeos annually while treating around 8,000 cases. Learn more about the Justin Sportsmedicine Team® at justinsportsmedicineteam.com.

About Justin Boots

Justin Boots is a brand of western footwear that was founded in 1879 by H.J. Justin. The company is headquartered in Fort Worth, Texas, and produces a wide range of boots for both men and women, including cowboy boots, work boots, and casual shoes. Justin Boots is known for its high-quality craftsmanship and use of premium materials, and has a reputation for being a trusted brand in the western footwear market. For more information, visit justinboots.com.

Facebook: @JustinBoots | Twitter: @JustinBoots | Instagram: @JustinBoots_

Share article on social media or email:

Buford, Georgia’s, Buford Family Dental recognized as a 2023 Top Patient Rated Dentist by Find Local Doctors


News Image

“We are honored to receive this award, as our patient’s comfort is always a top priority, along with providing them with exceptional oral health care,” says Dr. Ravi Patel of Buford Family Dental.

As a comprehensive family dental practice, Buford Family Dental serves its community with the very best. The talented and experienced dental team excels in multiple facets of dentistry, including general, pediatric, restorative and cosmetic dentistry as well as orthodontics (OrthoFX). Their extensive skill set and patient-centered approach to dental care have largely contributed to the practice’s recognition. Buford Family Dental has earned the Top Patient Rated Dentist award due to the numerous outstanding reviews and five-star ratings from patients. Find Local Doctors is a credible online directory that helps consumers locate reputable physicians and dentists in their geographical area. Patients in the Atlanta and Buford area can receive complete dental care for every stage of life in one place, such as advanced periodontal therapy, porcelain veneers and dental implants. The clinic features cutting-edge equipment, comfortable amenities and easy scheduling options for a stress-free visit. Buford Family Dental offers patients the convenience of emergency dental care, same-day appointments, insurance plan acceptance and advanced, modern dentistry.

“We are honored to receive this award, as our patient’s comfort is always a top priority, along with providing them with exceptional oral health care,” says Dr. Ravi Patel of Buford Family Dental.

More about Buford Family Dental:

Dr. Ravi Patel was born in Georgia and completed his undergraduate degree from Indiana University before earning his master’s degree at Purdue University. Dr. Patel then completed his doctorate from Nova Southeastern University’s College of Dental Medicine. He is passionate about providing quality and comfortable dentistry for the entire family. Dr. Patel also runs Sleep Better Atlanta, which is associated with Buford Family Dental and treats chronic snoring, sleep apnea and bruxism which all negatively impact sleep and health. Dr. Sun Kim graduated from the University of Georgia with a bachelor’s degree in microbiology. He later attended the Dental College of Georgia at Augusta University to complete his dental degree. Dr. Kim believes in patient-focused care and providing information to help them achieve their best smiles.

Dr. Rohit Mukhi went to The University of Georgia where he received a BS in biology in 2016. He later moved to Augusta, Georgia, to attend The Dental College of Georgia at Augusta University, where he was awarded his dental doctorate degree. Dr. Mukhi is a trusted, accomplished and ethical dentist who believes in always putting his patients first.

Buford Family Dental is located at 4700 Nelson Brogdon Boulevard in Buford, Georgia. For more information about the services offered at Buford Family Dental, please visit http://www.bufordfamilydental.com or call (678) 730-2005.

Share article on social media or email: